It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
China has reported its highest number of daily coronavirus infections in almost six weeks, largely because of infected people arriving in the country from overseas. A total of 108 new cases were declared on the mainland by the national health commission on Monday, of which 98 were imported - a new record for such cases, and fuelling fears that China could experience a second wave of infections brought in from abroad. With the lockdown now easing in the city of Wuhan, where the Covid-19 outbreak began, Chinese cities and towns near the border with Russia are being seen as the new frontline in the country’s virus response. Health officials said that of the new cases for Sunday, 49 were Chinese nationals who entered Heilongjiang province from Russia and tested positive. Border checkpoints are being tightened, and cities near the border are imposing stricter quarantines in response to the influx of patients
originally posted by: Silcone Synapse
a reply to: Agit8dChop
Thanks for your hard work on this thread AChop.
I reckon its probably the biggest thread ATS has ever had if you count all the parts together.
Well,the UK Government and NHS have partnered up with apple and google to set up a contact tracking covid19 app for mobile phones..
Its voluntary(for now)so thats one good thing I suppose.
But it uses Bluetooth!
So apart from the obvious privacy issues,we are supposed to leave bluetooth on all the time,opening ourselves up to potential worms,(computer)viruses and hack attacks-not to mention say goodbye to your phones battery life in short order.
www.bbc.co.uk...
I don't think I will be using this app-but then I am already concerned with how the governments of the world seem to be using the pandemic as an excuse to ramp up the ripping away of freedoms and the acceleration of their totalitarian police state dreams.
As always-Stay safe everyone.
"We don't expect to make any changes to the measures currently in place at that point and we won't until we're confident, as confident as we realistically can be, that any such changes can be safely made," he said.
He told the daily Downing Street news conference that easing restrictions too early would "risk a second wave" of infections.
originally posted by: pavil
a reply to: odd1out
The majority of patients in this international cohort demonstrated clinical improvement and no new safety signals were identified with remdesivir treatment,” Gilead said in a statement.
How is that any better than the other drug mix? Their study was only 56 patients and only a majority? The Chlor-Zpack has had studies of over a 1000 patients with 80%+ improvement rates. Other studies had even higher success rates.
It's all about the Benjamins not saving the most lives.
The coronavirus mutation that threatens the race to develop vaccine
A strain found in India showed changes in the mechanism used to bind the virus to human cells which could render current research futile
Researchers are targeting the same process that allowed Sars to infect people, but the mutation could upend their assumptions
www.scmp.com...
A coronavirus strain isolated in India carried a mutation that could upend vaccine development around the globe, according to researchers from Australia and Taiwan.
The non-peer reviewed study said the change had occurred in part of the spike protein that allows the virus to bind with certain human cells.
This structure targets cells containing ACE2, an enzyme found in the lungs which also allowed the severe acute respiratory syndrome (Sars) virus to infect people.
Scientists know more about this receptor than any other so had been working on antibodies that target it, but an unexpected structural change could render them useless.
“The observation of this study raised the alarm that Sars-CoV-2 mutation with varied epitope [something an antibody attaches itself to] profile could arise at any time,” they wrote in a paper released on preprint review site biorxiv.org on Saturday.
“[This] means current vaccine development against Sars-CoV-2 is at great risk of becoming futile.
The researchers found that the mutation occurred in the spike protein’s receptor-binding domain (RBD).
A computer simulation shows that the RBD mutation, which was not found in other variants across the globe, could remove a hydrogen bond from the spike protein.
Without this bond, the virus may be less likely to bind with ACE2, or angiotensin converting enzyme-2, which is found in the lungs and other organs.
Since its first confirmed identification in early January, the virus has reached every continent except for Antarctica with more than 3,500 mutations detected, according to the China National Centre for Bioinformation.
Austria came to a standstill when it introduced lockdown measures on March 16. The country closed everything except supermarkets and medical facilities. Thomas Kaschowitz’s men’s fashion store in the center of Vienna has been firmly shut for four weeks, which has cost him some €50,000 ($54,724) in turnover. But last week Austria became the first European country to announce it would begin lifting its lockdown measures. Kaschowitz's store is one of the ‘non-essential' businesses that will be allowed to reopen after the Easter weekend. The move was hailed by the media as a sign that the continent was beginning to beat the coronavirus, but Kaschowitz remains skeptical about its effect.
The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. The new saliva collection method, which RUCDR developed in partnership with Spectrum Solutions and Accurate Diagnostic Labs (ADL), will allow for broader population screening than the current method of nose and throat swabs. “The impact of this approval is significant,” said Andrew Brooks, chief operating officer and director of technology development at RUCDR, who also is a professor in the School of Arts and Sciences Department of Genetics at Rutgers University–New Brunswick. “It means we no longer have to put health care professionals at risk for infection by performing nasopharyngeal or oropharyngeal collections.
“After many days in which we’ve seen rises in cases of the coronavirus infection, the numbers are looking like we may be at or near the peak of the epidemic. We’re seeing a stabilizing in our daily case count and also it looks like a stabilizing the number of cases at the hospitals,” Philadelphia Health Commissioner Dr. Thomas Farley said.